Ligand Pharmaceuticals
Price & Volume
Stats
See more52W Range | $175.89-$326.63 |
Market Cap | $6.4B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $306.8M |
Revenue Growth (YoY) | -31.8% |
Gross Profit (12 Mos) | $271.6M |
Diluted EPS | $9.49 |
News
See moreYahoo Finance • 6 days ago
Ligand raises 2026 adjusted EPS guidance to $9.50-$9.75 while targeting ~$200M annual capital deployment
Yahoo Finance • last month
Is Ligand Pharmaceuticals (LGND) Using AvenCell CAR-T Royalties To Redefine Its Cash-Flow Playbook?
Yahoo Finance • 2 months ago
Axsome Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance • 2 months ago
Ligand Pharmaceuticals Highlights XOMA-Fueled Royalty Growth, $700M in Deployable Capital
About
CEO | Mr. Todd C. Davis Ph.D. |
Address | 555 Heritage Drive, Jupiter, FL, United States, 33458 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 47 |